SameTaste, an Israeli-based company, recently claimed to have achieved what all the major tobacco companies are actively seeking: a vape liquid that produces the exact same personal experience of legacy tobacco cigarettes
Innocan Pharma operates three primary and distinct segments: research and development (R&D) of CBD-loaded exosomes, R&D of the use of CBD-loaded liposomes, and commercialization and sale of branded CBD-integrated pharmaceutical and topical treatment products
Ayurcann Holdings, led by CEO Igal Sudman, is one of Canada's youngest but most distinguished and nominated cannabis extraction and processing companies. The CEO reveals Ayurcann's 2022 strategic plan to key investors
Dr. Philip Moshe and Eran Atlas are possibly the most influential duo in the Diabetes world over the past two decades as the developers of the AI algorithms behind Medtronic's artificial pancreas and world's first Endocrinology digital expert
Eco Atlantic Oil & Gas' CEO Gil Holzman is one of the world's most creative and resourceful energy executives that has helped transform petroleum exploration company Eco Atlantic Oil & Gas into a global enterprise developing new projects with prominent partners
Earlier this year, Richard Serbin joined Canadian-Israeli pharmaceuticals company InnoCan Pharma as a consultant. Now the former Johnson & Johnson Vice President and FDA Counsel is already making a major impact: this month he was a featured speaker with InnoCan's CEO Iris Bincovich at the iCDP Conference in Boston
Since its founding in 2018, InnoCan Pharma has been capturing headlines with its research and development of smart delivery platforms and leading advisory team. Last year, InnoCan added Peter Bloch, one of the industry's foremost health-tech executives
Hear from the CEO of NurExone Biologic Ltd, Israel's promising new start-up which aims to utilize innovative Exosome-based technology and smart delivery platforms in order to revolutionize the way spinal cord injury (SCI) is treated around the world
InnoCan Pharma has officially launched common shares trading on the OTCQB Venture Market, placing the promising pharmaceuticals company in the next stage of its strategic commercialization plan
Analysts predict that China is boycotting all foreign cryptocurrencies in efforts to promote the use of its official national cryptocurrency Digital Yuan
After adding Johnson & Johnson's former vice-president of corporate development and FDA counsel to its advisory board, InnoCan Pharma's future seems bright, and investors are taking notice
Alkemy (TSX: AKMY.V) debuts mining of non-recyclable plastics that aims to rid the world from its number one pollutant while transforming it into 100 per cent recycled plastics-based goods
Yuan Pay Group's cryptocurrency trading platform gives Western investors an early opportunity to profit off the growth of the rising Chinese economy, making it now easier than ever to invest in China
Alkemy, to be listed in Toronto (TSXV:AKMY.V), has developed and operates a highly profitable and unique process to recycle 'dirty plastic' that was deemed economically non-viable until today
Zoomd Technologies' ($ZMDTF, $ZOOMD) marketing technology and expansion into large and strategic global markets, including Eastern Europe, East Asia and Southeast Asia, has its stock soaring and investors invested for 2021
Today, there are several cannabis-related companies listed via Canadian securities, making it a major marketplace for pain-relieving products around the globe